Acute Myocardial Injury Assessed by High-Sensitive Cardiac Troponin Predicting Severe Outcomes and Death in Hospitalized Patients with COVID-19 Infection
- PMID: 35360970
- PMCID: PMC8979852
- DOI: 10.1177/10760296221090227
Acute Myocardial Injury Assessed by High-Sensitive Cardiac Troponin Predicting Severe Outcomes and Death in Hospitalized Patients with COVID-19 Infection
Abstract
Background: Cardiac injury has been linked to a poor prognosis during COVID-19 disease. Nevertheless, the risk factors associated are yet to be thoroughly investigated.
Objectives: We sought to compare demographical characteristics and in-hospital outcomes in patients infected by the SARS-CoV-2 with and without cardiac injury, to further investigate the prevalence of acute cardiac injury as well as its impact on their outcomes in COVID-19-patients.
Methods: We included in a retrospective analysis, all COVID-19 patients admitted between October first and December first, 2020, at the University Hospital Center of Oujda (Morocco) who underwent a troponin assay which was systematically measured on admission. The study population was divided into two groups: cardiac-injured patients and those without cardiac injury. Clinical, biological data and in-hospital outcomes were compared between the two groups.
Results: 298 confirmed COVID-19 cases were included. Our study found that compared to non-cardiac-injured, cardiac-injured patients are older, with higher possibilities of existing comorbidities including hypertension (68 [42.2%] vs 40 [29.2%], P = 0.02), diabetes (81 [50.3%] vs 53 [38.7%] P = 0.044), the need for mechanical ventilation, ICU admission and mortality. A Cox proportional hazards regression analysis shows a significantly increased risk of death among cardiac-injured COVID-19-patients as compared to non-cardiac injured. (HR, 1.620 [CI 95%: 2.562-1.024]).
Conclusion: Our retrospective cohort found that old age, comorbidities, a previous history of CAD, were significantly associated with acute cardiac injury. COVID-19 patients with acute cardiac injury are at a higher risk of ICU admission, and death.
Keywords: COVID-19; biomarkers; cardiology; mortality.
Conflict of interest statement
Figures
Similar articles
-
Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study.JAMA Cardiol. 2020 Nov 1;5(11):1274-1280. doi: 10.1001/jamacardio.2020.3538. JAMA Cardiol. 2020. PMID: 32845276 Free PMC article.
-
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.JAMA Cardiol. 2020 Jul 1;5(7):802-810. doi: 10.1001/jamacardio.2020.0950. JAMA Cardiol. 2020. PMID: 32211816 Free PMC article.
-
Myocardial injury in patients with SARS-CoV-2 pneumonia: Pivotal role of inflammation in COVID-19.Eur J Clin Invest. 2022 Jan;52(1):e13703. doi: 10.1111/eci.13703. Epub 2021 Nov 11. Eur J Clin Invest. 2022. PMID: 34706062 Free PMC article.
-
Prevalence and clinical outcomes of cardiac injury in patients with COVID-19: A systematic review and meta-analysis.Nutr Metab Cardiovasc Dis. 2021 Jan 4;31(1):2-13. doi: 10.1016/j.numecd.2020.09.004. Epub 2020 Sep 11. Nutr Metab Cardiovasc Dis. 2021. PMID: 33229199 Free PMC article.
-
Special Article - Acute myocardial injury in patients hospitalized with COVID-19 infection: A review.Prog Cardiovasc Dis. 2020 Sep-Oct;63(5):682-689. doi: 10.1016/j.pcad.2020.05.013. Epub 2020 Jun 6. Prog Cardiovasc Dis. 2020. PMID: 32512122 Free PMC article. Review.
Cited by
-
Dynamic of Serum TWEAK Levels in Critically Ill COVID-19 Male Patients.J Clin Med. 2022 Jun 27;11(13):3699. doi: 10.3390/jcm11133699. J Clin Med. 2022. PMID: 35806986 Free PMC article.
-
Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2.World J Virol. 2022 Sep 25;11(5):375-390. doi: 10.5501/wjv.v11.i5.375. World J Virol. 2022. PMID: 36188743 Free PMC article.
References
-
- Aggarwal S, Garcia-Telles N, Aggarwal G, Lavie C, Lippi G, Henry BM. Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): early report from the United States. Diagnosis (Berl ). 2020;7(2):91-96. doi: 10.1515/dx-2020-0046. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous